Kenvue Inc. (KVUE)

8 members of Congress have disclosed trading KVUE — 5 purchases and 8 sales worth an estimated $128,500. Most recent disclosure: Mar 13, 2026.

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Company website ↗

• P/E ratio (22.8) — how many dollars you pay for each $1 of KVUE's yearly profit. That's a fairly normal range.
• ROE (15.70%) — how efficiently the company turns shareholders' money into profit. This is a middling level.
• Profit margin (10.61%) — of every $1 in sales, this is what's left as profit after all costs.
• Dividend yield (4.34%) — the cash payout you'd earn per year as a % of the share price, on top of any price gains.